학술논문
Preclinical assessment of AMG 596, a bispecific T-cell Engager (BiTE) immunotherapy targeting the tumor-specific antigen EGFRvIII
Document Type
Article
Author
Source
In: Molecular Cancer Therapeutics . (Molecular Cancer Therapeutics, May 2021, 20(5):925-933)
Subject
Language
English
ISSN
15388514
15357163
15357163